These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23521357)

  • 1. Clinicopathological prognostic indicators in 107 patients with diffuse large B-cell lymphoma transformed from follicular lymphoma.
    Maeshima AM; Taniguchi H; Fukuhara S; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Cancer Sci; 2013 Jul; 104(7):952-7. PubMed ID: 23521357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses.
    Maeshima AM; Omatsu M; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
    Cancer Sci; 2008 Sep; 99(9):1760-8. PubMed ID: 18549405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.
    Magnano L; Balagué O; Dlouhy I; Rovira J; Karube K; Pinyol M; Rivas-Delgado A; Costa D; Martínez-Trillos A; González-Farre B; Martínez-Pozo A; Giné E; Colomer D; Delgado J; Villamor N; Campo E; López-Guillermo A
    Ann Oncol; 2017 Nov; 28(11):2799-2805. PubMed ID: 29045517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
    Qu Z; Zhang T; Gao F; Gong W; Cui Y; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Li L; Wang X; Zhang H
    Biomed Res Int; 2022; 2022():4379556. PubMed ID: 35655476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients.
    Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED
    Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
    Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
    Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Analysis of 320 Cases of Diffuse Large B-cell Lymphoma Using the Hans Classifier.
    Ichiki A; Carreras J; Miyaoka M; Kikuti YY; Jibiki T; Tazume K; Watanabe S; Sasao T; Obayashi Y; Onizuka M; Ohmachi K; Yoshiba F; Shirasugi Y; Ogawa Y; Kawada H; Nakamura N; Ando K
    J Clin Exp Hematop; 2017; 57(2):54-63. PubMed ID: 29021515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Features of Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma].
    Zhang XL; Yu WJ; Zhu YN; Yang CM; Xiao F; Mai WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1772-1778. PubMed ID: 36476902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
    Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
    Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with
    Uryu H; Mishima Y; Tsuyama N; Yokoyama M; Nishimura N; Fukuta T; Shirouchi Y; Okabe T; Inoue N; Takeuchi K; Terui Y
    Leuk Lymphoma; 2021 Sep; 62(9):2141-2150. PubMed ID: 33749498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.
    Tomita N; Takasaki H; Fujisawa S; Miyashita K; Ogusa E; Kishimoto K; Matsuura S; Sakai R; Koharazawa H; Yamamoto W; Fujimaki K; Fujita H; Ishii Y; Taguchi J; Kuwabara H; Motomura S; Ishigatsubo Y
    J Clin Exp Hematop; 2013; 53(2):121-5. PubMed ID: 23995108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
    Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
    J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10
    Azoulay D; Cohen HI; Dementiev E; Eshel E; Akria L; Shaoul E; Horowitz N
    Cytometry B Clin Cytom; 2020 Sep; 98(5):449-453. PubMed ID: 31816181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diffuse large B-cell lymphoma developed newly after 9-year remission of a follicular lymphoma].
    Hirano T; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Tsuda H
    Rinsho Ketsueki; 2016 Feb; 57(2):171-4. PubMed ID: 26935635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic transformation of follicular lymphoma: pathologists' viewpoint.
    Maeshima AM
    J Clin Exp Hematop; 2023; 63(1):12-18. PubMed ID: 36990772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases.
    Maeshima AM; Taniguchi H; Ida H; Hosoba R; Fujino T; Saito Y; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Hum Pathol; 2020 Aug; 102():33-43. PubMed ID: 32540222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signet-ring cell lymphoma: clinicopathologic, immunohistochemical, and fluorescence in situ hybridization studies of 7 cases.
    Zhang S; Sun J; Fang Y; Nassiri M; Liu L; Zhou J; Stohler R; Choi H; Vance GH
    Ann Diagn Pathol; 2017 Feb; 26():38-42. PubMed ID: 28038709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
    Kim S; Nam SJ; Kwon D; Kim H; Lee E; Kim TM; Heo DS; Park SH; Kim CW; Jeon YK
    BMC Cancer; 2016 Jun; 16():363. PubMed ID: 27286976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.